The editors of this Journal choose to dedicate this issue to our colleague Louis Sokoloff. This month (October) marks his 70th year, more than 42 of which have been spent in research on cerebral cir culation and metabolism. His choice of this area had its origin in 1947 while on active duty in the U. S. Army. Because he had acquired a consider able experience in psychiatry during an extended internship, he was made head of one of the units created to serve the needs of service men and women with mental disorders resulting from active duty in World War II. A combination of clinical experience, keen intuition, and knowledge acquired as a brilliant student (he ranked second in his med ical school class) led to his being given a large re sponsibility and rapid promotion. We judge from his many anecdotes about the experiences in these years that, unencumbered by psychoanalytic no tions of the time, he was a shrewd clinician keenly sensitive to the misery endured by many of his pa tients. But, uncomfortable with the purely descrip tive criteria used in making diagnoses and im pressed by the ineffectiveness of the various modes of therapy, he became convinced that there were physiologic and biochemical disturbances to ac count for the signs and symptoms of mental illness. On reading the account of the nitrous oxide method for the quantitative measurement of cerebral blood flow and oxygen consumption by his former teach ers Seymour Kety and Carl Schmidt at the Univer sity of Pennsylvania (Kety and Schmidt, 1948) , he believed that this method might be a powerful tool for the study of psychiatric disorders. Therefore, on discharge from the army, he decided to return to his alma mater and apply for a fellowship in the Depart ment of Physiology and Pharmacology in the Grad uate School of Medicine. He became the second of Kety's fellows.
The Department was then headed by the pulmo nary physiologist Julius Comroe, who made rigor ous demands on all fellows over and above their commitment to research projects. Preparation and delivery of lectures, thorough scholarship, an inci sive writing style, and intimate knowledge of instru ments used in research were given highest priority Electronics, Lou's major hobby, somehow fit into the scheme of things. The principles employed in the design and construction of his own high-fidelity amplifier served to enhance his understanding of both pulmonary and circulatory physiology. The grant from which Sokoloff was paid dealt with an other blood flow method developed by Kety, the 24Na + clearance method (Kety, 1949) , which was to be evaluated in muscle. Therefore, Sokoloff was required to divide his laboratory time between stud ies in cerebral and muscle blood flow. He viewed this as fortunate because he was introduced to ra dioisotopic techniques requiring the knowledge of the physics of radioactivity, a new subject in bio medical research at the time. Also, because the clearance method was based on kinetic modeling and mathematical analysis of the model, he was compelled to extend his knowledge of mathematics to be useful in this area. The climate of this fellow ship, unlike that of most today, was one of learning and preparation for research, with little immediate concern over pUblications. A paper was seen only as a natural outcome of carefully planned and well executed experiments designed to answer an impor tant question. Its quality was far more important than the number of papers generated in a given pe riod of time. Indeed, the first paper on which Sokoloff was listed as a coauthor did not appear until more than 3 years after starting his fellowship; one on which he was first author appeared 4 years later.
Lou was married to nurse and aircraft pilot Betty Kaiser in 1947. She patiently endured Lou's monas tic life in the laboratory. Beginning with the years before children arrived, when her only home com panion was the devoted Sheltie, Rhett, she was a gracious hostess. Her study of cuisine continued while raising a family, and even later after returning to hospital duties as night nursing supervisor. She now has a worldwide circle of appreciative friends and former guests.
By 1950 the results obtained with the nitrous ox ide method in a variety of disorders, e. g. , barbitu rate anesthesia, diabetic coma, insulin hypoglyce mia, cerebrovascular disease, indicated that the overall metabolic rate of the brain was depressed under various conditions. To determine whether the brain had the potential to increase its metabolic rate, Lou decided to study hyperthyroidism, a con dition marked by mental symptoms and in which the metabolic rate of the body as a whole was known to be elevated. His measurements of cere bral oxygen consumption in patients both before and after treatment for their hyperthyroidism yielded values that were unchanged from normal levels (Sokoloff et al. , 1953) . This seemingly para doxical finding posed new questions that were to be pursued in an extended career tour into biochemis try years later.
With the departure of Seymour Kety to become the first Scientific Director of the combined Intra mural Research Programs of the National Institute of Mental Health and the National Institute of Neu rological Diseases and Blindness, Lou became somewhat isolated as the only remaining one in Comroe's department engaged in studies of cerebral metabolism. In 1953 he therefore accepted Kety's invitation to come to NIH. Here, while a number of projects involving the nitrous oxide method were being completed, he was able to return to the ques tion of the effects of thyroid hormone on cerebral metabolism. Knowledge of the intimate role played by thyroid hormone in the regulation of protein syn thesis in most tissues led him to examine the mech anism of this effect. This required his becoming im mersed in learning and practicing biochemistry. In collaboration with Seymour Kaufman, he set up an assay for protein synthesis in vitro, and after many years of repeated long experiments, the first of an important series of papers appeared in the Journal of Biological Chemistry, demonstrating that L-thy roxine stimulates amino acid incorporation into pro tein both in vitro and in vivo in a process that is mitochondria dependent (Sokoloff and Kaufman, 1961) . The earlier finding of a failure to detect an elevation of cerebral oxygen consumption in hyper thyroidism proved to reflect the fact that oxidative metabolism associated with thyroxine-stimulated protein turnover in mature brain is small compared with that required for the maintenance of normal consciousness. In this period, while days were oc cupied with experiments, evenings into the wee morning hours were given to writing a review on the action of drugs on the cerebral circulation for Phar macological Reviews (Sokoloff, 1959) . This proved to be a classic for years to come. But the work on thyroxine and protein synthesis in brain continued for the next 10 years, resulting in over 30 publica tions, several of which added much to our knowl edge of the role of thyroxine in brain maturation.
J Cereb Blood Flow Metab, Vol. 11, No.6, 1991 A puzzling question often arose. What accounts for the unchanged cerebral metabolic rates in such diverse circumstances as sleep, solving arithmetic problems, thought in schizophrenia, and LSD in toxication? The most appealing explanation was that these states are accompanied by changes in local cerebral metabolism, but that the changes can not be detected in measurements of average meta bolic rate of the brain as a whole. Clearly what was needed was a method for measuring local metabolic rates. While the feasibility of such a method could not be envisaged at the time, Kety, in his presenta tion of the principles of inert gas exchange between blood and tissues (Kety, 1951) , had derived an equation that suggested an approach to the problem by measurements of local cerebral blood flow (Kety, 1960) . It was known that blood flow in brain under most circumstances is adjusted to metabolic rate and measurements of local blood flow would therefore provide an index of local energy metabo lism. The development of a local blood flow method had been initiated by Kety together with Walter Freygang and William Landau. This method was based in the use of [131 I]trifluoroiodomethane and quantitative autoradiography. At the time the abil ity to use optical density in an autoradiograph to determine the concentration of a labeled substance in brain was considered only as an essential techni cal step in the development of the blood flow method, but in fact the creation of a successful pro cedure for this purpose was an important contribu tion in itself. Replacing dissection and analysis of tissue fragments, quantitative autoradiography made possible the measurement of the local concen tration of a radiolabeled substance in any small re gion of the entire brain without disturbing normal anatomic relationships. It was later to be an essen tial part of many neurochemical and neuroanatom ical methods. The local cerebral blood flow method was completed in 1955 (Landau et al. , 1955) , and its later application in a study of the effect of retinal stimulation with flashes of light in cats revealed the blood flow to all components of the visual system to be selectively increased (Sokoloff, 1961) . The auto radiograms of that study were the first examples of imaging of local cerebral functional activity.
Lou continued to think about a method by which local metabolic rates could be measured directly in brain. In 1955-56 he had developed a model for the measurement of glucose utilization in brain with e4C]glucose. From a few experiments it was appar ent that the early loss of labeled products of e4C]glucose metabolism, mainly 14COZ' would ne cessitate very short experimental periods. A large error would be introduced because of the time lag for the labeled glucose to reach tissue pools from the plasma. The project was shelved. But in 1957, through Donald Tower in an adjacent laboratory, Lou became familiar with some of the pharmaco logic properties of 2-deoxyglucose. A study of the literature revealed that it was phosphorylated like glucose by hexokinase but the product, 2-deoxyglu cose-6-phosphate, could not be converted to fruc tose-6-phosphate, the next step in the glycolytic pathway (Sols and Crane, 1954) . 2-Deoxyglucose-6-phosphate could accumulate in brain to relatively high levels because it was a poor substrate for most enzymes present in brain and because glucose-6phosphatase activity is very low in brain. These properties suggested to him that deoxyglucose, la beled with 14C, could be used as a tracer for glucose with the auto radiographic technique that had been devised for the local cerebral blood flow method. But with Lou being occupied in the studies on the actions of thyroid hormones, the development of an operational method had to wait.
A modification of the quantitative autoradio graphic technique for use with [14C]antipyrine was accomplished by Martin Reivich, who joined Sey mour Kety and Lou in the laboratory at NIMH for a stint in 1965 (Reivich et aI. , 1969) . They later dem onstrated that [14C]deoxyglucose and glucose were taken up by brain slices from the incubation me dium in proportionate amounts. A model modified from that used for the local blood flow method was then designed and an equation derived that would allow the calculation of local glucose utilization, provided local blood flow and other factors difficult to determine were also known (Reivich et aI. , 1971 ). The operational equation derived from this model proved impractical and the project again came to a halt. While on a sabbatical year at the College de France in 1968, Lou worked with Jacques Nunez and Jacques Pommier in studies of peroxidase catalyzed iodination of proteins. In the course of this work, he became facile with models involving enzyme kinetics, and it occurred to him that a new approach might be taken to the development of a method for measuring local glucose utilization in brain. A new model would be based on the enzyme kinetic behavior of deoxyglucose in the tissue rather than merely blood flow and tissue-blood ex change. On his return from France, a mathematical analysis of this new model led to the formulation of an operational equation suitable for evaluation in experimental work. The method was fully devel oped in about 3 years and was presented together with results in normal conscious animals at the an nual meeting of the American Society for N euro chemistry in New Orleans in March 1974. Its use-fulness for metabolic mapping was initially demon strated in the visual pathways of the rat (Kennedy et aI. , 1975) and monkey (Kennedy et aI. , 1976) , and a complete account of the theory, procedure, and normal values in conscious and anesthetized rats appeared in 1977 (Sokoloff et aI. , 1977) .
The members of Lou's laboratory, together with fellows and many collaborating visitors, thrived in the conduct of experiments measuring local glucose utilization in differing behavioral states, seizures, during development, during various modalities of sensory stimulation, and following the administra tion of drugs. Thereby those who had not been di rectly involved in the method's development came to appreciate its elegance as well as its limitations. A collaboration with Wayne Rasband and Charles Goochee made possible an image-processing sys tem by which the massive amount of data from each experiment could be displayed in color-coded im ages. The images allowed the simultaneous quanti tative assessment of metabolic rates in all brain structures in conscious, behaving animals by simple inspection (Goochee et aI. , 1980) . New relation ships were revealed and the full constellation and degree of participation of structures simultaneously activated or inhibited as a result of a given behavior or response to stimulation were demonstrated for the first time. Then the question arose: What is the site of increase in glucose utilization resulting from stimulation, cell body or neuropil? A diverse group of experiments with several collaborators provided strong evidence that the metabolic response is in axon terminals or neuropil, not the cell body (Schwartz et aI. , 1979; Mata et aI. , 1980; Kadekaro et aI. , 1985) . Other questions included: Is glucose utilization altered by extreme hyperglycemia; hypo glycemia; seizures? If so, how? Lou's intimate fa miliarity with kinetics made possible the design of experiments to answer these questions. Critics fo cused on the difficulty in obtaining accurate esti mates of the rate constants of the operational equa tion, questioning their validity in various condi tions. Slowly, it seems, there was an appreciation that the ingenious arrangement of the terms in the operational equation, together with the specified re quirement for the deoxyglucose to circulate in the plasma for an extended period following its intrave nous administration (about 45 min), eliminates the effect of even large errors in the estimates of the rate constants on calculated rates of glucose utili zation. Not surprisingly, the method came into wide use, the extent being reflected by the original pa per's having achieved the status as a Citation Clas sic in 1989 (Sokoloff et aI. , 1977) .
Not long after the e4C]deoxyglucose method was developed and validated, Reivich pressed Lou for help in adapting the method for use in human sub jects. Such an adaptation, of course, was dependent upon the ability to measure local concentrations of label by external detection. David Kuhl, then in the Department of Radiology at the University of Penn sylvania, had previously constructed a section scanner that could measure local concentrations of "i-emitting isotopes in cross sections of human brain by external scintillation counting. Through Alfred Wolf, a radiochemist at Brookhaven National Lab oratory, 2-esP]fluoro-2-deoxY-D-glucose was syn thesized and was found in Lou's laboratory to re tain the essential biochemical properties of deoxy glucose. The 2-esp]fluorodeoxyglucose adaptation of the deoxyglucose method was used for the first time in humans with Kuhl's Mark IV Section Scan ner (Reivich et aI., 1979) . But positron emission to mography offered the prospect of better spatial res olution and accuracy than Kuhl's single photon scanner. Kuhl's coworkers, Michael Phelps and Edward Hoffman, both pioneers in the design and use of positron emission tomographs, adapted the method for use with "PET" after their move to UCLA (Phelps et aI., 1979) . The deoxyglucose method applied to both ani mals and human subjects has been a boon to those pursuing the study of brain function. Although Lou is quick to say that the method's validation has been established only for physiologic states, there is no reason to doubt the findings by several groups in such neurological disorders as epilepsy, Hunting ton's disease, and parkinsonism. Because brain tu mors are characterized by an altered blood-brain barrier, have an uncertain phosphatase activity and have an unknown lumped constant, Lou showed little interest in employing the deoxyglucose method in a project on experimental gliomas in rats some years ago. It now seems that one m<\ior fea ture of many malignancies is a relatively high rate of [lsP]fluorodeoxyglucose uptake, strongly suggest ing that there is a corresponding elevation in their rate of glucose utilization. It is likely that this char acteristic of malignancies will greatly increase the use of eSp]fluorodeoxyglucose in the evaluation of patients at risk for cancer. But to the extent that its use would be solely for detection by imaging, Lou could be expected to have little interest, citing an aphorism by Lord Kelvin that hangs prominently on his office wall, "When you cannot express it in numbers, your knowledge is of a meager and unsat isfactory kind." In his remarks about studies in ischemia, he is similarly diffident, likening infarcted tissue to a compost pile. In recent years, however, his attitude has given way to a feeling of challenge J Cereb Blood Flow Metab, Vol. 11, No.6, 1991 to make possible the use of the deoxyglucose method in pathophysiologic conditions. If the lumped constant of the deoxyglucose method were known in regions of brain having pathological changes, for instance, glucose utilization could in deed be determined in such regions. His laboratory is presently engaged in a project in which the local lumped constant can be measured in the same ex periment in which the rate of glucose utilization is measured.
As he enters his 71st year, Lou's life style re mains unchanged from that of years ago: tennis on Sundays, retirement never a consideration. While running an active research program at NIMH, he is much sought after by friends, acquaintances, and colleagues for advice in planning their work and even in interpreting the findings. His stature as ad visor is more formally reflected in many appoint ments as consultant and board, panel, and commit tee membership on a long list of university depart ments and research organizations. Because of his broad experience in many areas of science, he has served on editorial boards of journals devoted to widely differing disciplines and continues to be an authoritative referee of papers on diverse subject matter. A recipient of honorary degrees from the Universities of Lund, Glasgow, and Marburg and Yeshiva University, he has also received a number of prestigious and awards including the P. O. Schmitt Award (1980), Albert Lasker Award (1981), Lashley Award (1987, American Philosophical So ciety), the U.S. National Academy of Sciences Award in the Neurosciences (1988), the Mihara Award, Japan (1988), to name only a few. He is in continuous demand to give honorary lectures. We wish him continued good health and sustained in tellectual vigor that he may extend his unique con tributions in neuroscience and remain a rigorous critic in a world where quality is so often diminished by the quest for the secondary gains of a scientific career. 
Charles Kennedy

